Acadia Healthcare Company issued the following statement with respect to a government investigation separately disclosed by the Company. Acadia is cooperating fully with the authorities regarding this matter. “Ensuring we provide the highest quality of care is personal for me and the number one priority for my colleagues across the Company,” said Acadia Chief Executive Officer Chris Hunter. “We take seriously our patient care and compliance responsibilities and understand how critical it is to provide these services with excellence and compassion. We’re committed to taking action on incidents that fall short of our rigorous standards and are making investments necessary to establish Acadia as the leading behavioral healthcare provider for high-acuity and complex needs patients.”
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia to pay $19.85M to settle allegations of medically unnecessary services
- New York Times investigation finds Acadia breaks law by holding patients
- Acadia Healthcare price target lowered to $83 from $89 at Barclays
- Acadia Healthcare narrows FY24 EPS view to $3.45-$3.65 from $3.40-$3.70
- Acadia Healthcare reports Q2 EPS 91c, consensus 87c